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Optic nerve injuryNeurotrophic factor and cAMP-dependent signaling promote the survival and neurite outgrowth of retinal gan-
glion cells (RGCs) after injury. However, the mechanisms conferring neuroprotection and neuroregeneration
downstream to these signals are unclear.We now reveal that the scaffold proteinmuscle A-kinase anchoring pro-
tein-α (mAKAPα) is required for the survival and axon growth of cultured primary RGCs. Although genetic de-
letion of mAKAPα early in prenatal RGC development did not affect RGC survival into adulthood, nor
promoted the death of RGCs in the uninjured adult retina, loss of mAKAPα in the adult increased RGC death
after optic nerve crush. Importantly, mAKAPαwas required for the neuroprotective effects of brain-derived neu-
rotrophic factor and cyclic adenosine-monophosphate (cAMP) after injury. These results identify mAKAPα as a
scaffold for signaling in the stressed neuron that is required for RGC neuroprotection after optic nerve injury.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Neuronal death following injury, including due to trauma or ische-
mia, remains an important source of long term disability with few
adequate therapies. In the eye, blindness can result from the death of
retinal ganglion cells (RGCs) that transmit visual information from the
retina via the optic nerve to the lateral geniculate, pretectal, and
superchiasmatic nuclei of the brain. Failure of central nervous system
(CNS) neurons, including RGCs, to survive and regenerate their axons
after injury results in part from a lack of adequate trophic signaling.
RGC death can be delayedby application of exogenousneurotrophic fac-
tors, such as brain-derived neurotrophic factor (BDNF), ciliary neuro-
trophic factor (CNTF), neurotrophin-4 (NT-4), ﬁbroblast growth factor
(FGF), and glial-derived neurotrophic factor (GDNF) (Mo et al., 2002,
Unoki and LaVail, 1994, Wang et al., 2013). This trophic signaling canof Pediatrics and Medicine,
hool of Medicine, University of
e at Stanford University, 2452
piloff), jlgoldbe@stanford.edu
uthors.
. This is an open access article underbe enhanced by electrical stimulation or elevation of intracellular cyclic
adenosine-monophosphate (cAMP) levels (Goldberg and Barres, 2000,
Goldberg et al., 2002, Corredor et al., 2012). How cAMP potentiates
the neuronal response to trophic factors is not well understood, al-
though inhibiting cAMP-dependent protein kinase (PKA), an enzyme
subject to tight spatial and temporal regulation in cells through its local-
ization by the diverse family of “AKAP” scaffold proteins (Scott et al.,
2013), blocks the positive effects of electrical activity and cAMP on neu-
ronal survival and axon growth (Goldberg et al., 2002).
Muscle A-kinase anchoring protein (mAKAP; also known as AKAP6)
is a 255 kDa scaffold protein localized to the nuclear envelope of neurons
and striated myocytes and that binds PKA as well as a large number of
signaling enzymes implicated in stress responses (Passariello et al.,
2015). mAKAP also binds the cAMP target Epac1, adenylyl cyclases
(types II and V), and the cAMP-speciﬁc phosphodiesterase 4D3. Because
these enzymes participate in negative and positive feedback, cAMP levels
are predicted to be tightly regulated aroundmAKAP “signalosomes,”pro-
viding local control over the phosphorylation of relevant PKA substrates.
Differential PKA localization by scaffolds like mAKAP is likely to be espe-
cially important in cell types like neuronswhere subcellular domains, in-
cluding cell bodies, axons and dendrites, are often separated across great
distances. In neurons, other AKAPs such as AKAP79 function in synaptic
signaling (Weisenhaus et al., 2010), but it is unknown whether anythe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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express the longer α isoform of mAKAP, mAKAPα, which contains an
amino-terminal sequence with additional binding sites, e.g. for 3-
phosphoinositide-dependent protein kinase-1 (PDK1) (Michel et al.,
2005).
The function of neuronalmAKAPα has not been characterized, albeit
deletion of the exon encoding the mAKAPα-speciﬁc N-terminus result-
ed in a failure-to-thrive phenotype (Michel et al., 2005). Besides binding
enzymes related to cAMP signaling, mAKAPα also binds in neurons the
mitogen-activatedprotein kinasesMEK5 and ERK5 that are known to be
important for neuronal survival in response to neurotrophins (Michel
et al., 2005, Dodge-Kafka et al., 2005, Wang et al., 2006, Watson et al.,
2001). Given that mAKAPα can coordinate cAMP and ERK5 signaling,
we hypothesized that mAKAPαmight be involved in survival or axon
growth signaling in neurons, which require both of these signaling
pathways to optimally promote these functions in RGCs(Goldberg
et al., 2002). We now present evidence that mAKAPα is expressed in
RGCs but discovered in fact thatmAKAPα does not regulate RGC surviv-
al during normal development or in the absence of injury, but rather
mediates stress-speciﬁc signaling of survival and axon growth in vitro
and survival in vivo after optic nerve injury.
2. Materials & Methods
2.1. Animals
All procedures were conducted in accordance with the ARVO State-
ment for the Use of Animals in Ophthalmic and Vision Research and the
University of California San Diego and University of Miami Institutional
Animal Care and Use Committees. All animals were randomly assigned
to experimental groups and littermates were used as controls.
For in vitro experiments, litters of Sprague Dawley rats (Harlan Labo-
ratories, Inc., Allen Park, MI) were used at postnatal day (P) 2–4 for isola-
tion of RGCs. For in vivo experiments, 20 female and 20 male (2 months
old) wildtype and mAKAPﬂ/ﬂ C57BL/6 mice were used (Kritzer et al.,
2014b). Cre recombination of the conditional mAKAP allele containing
LoxP sites surrounding exon 9 results in exon 9 deletion, frame-shift
and premature termination of translation within exon 10, 5′ of the
exons encoding the docking sites for many relevant mAKAPα-binding
partners, including nesprin-1α (conferring nuclear envelope localiza-
tion), calcineurin, PDE4D3 and PKA (Li et al., 2010, Pare et al., 2005,
Kapiloff et al., 1999). Note that no residual mAKAP N-terminal protein
fragment was detected following knock-out (Fig. 1C and data not
shown). A Math5-directed cre recombinase transgenic mouse was used
to direct developmental mAKAPα knock-out in the retina (Yang et al.,
2003, Tsien et al., 1996), while injection of AAV2 expressing both cre
and GFP marker protein (AAV2-Cre) was used to direct selective, induc-
ible knock-out in adult RGCs (Park et al., 2008). Heart extracts were ob-
tained from mAKAPβ knock-out and control mice of the following
genotypes following tamoxifen administration: Tg(Myh6-cre/Esr1*) /
mAKAPﬂ/ﬂ for knock-out and Tg(Myh6-cre/Esr1*) for control. All surgical
procedures were performed under general anesthesia via intraperitoneal
injection of ketamine (75 mg/kg) and xylazine (15 mg/kg). Mice also re-
ceived subcutaneous injection of buprenorphine (0.03 mg/kg; Bedford
Laboratories) as postoperative analgesic. Eye ointment containing eryth-
romycin was applied to protect the cornea.
2.2. Immunopanning of RGCs
RGCs were puriﬁed (N99.5%) from postnatal (P2 to P4) Sprague–
Dawley rats through sequential immunopanning, as previously described
(Goldberg et al., 2002). RGCs were cultured on poly-D-lysine (PDL;
70 kDa, 10 μg/mL; Sigma, St. Louis,MO) and laminin (1 μg/mL; Invitrogen,
Carlsbad, CA) in neurobasal (NB) serum-free deﬁnedmedium containing
insulin (5 μg/mL), sodium pyruvate (1 mM), L-glutamine (1 mM), triio-
dothyronine (T3; 40 ng/mL; Sigma), N-acetyl cysteine (NAC; 5 μg/mL;Sigma), B27 (1:50), BDNF (50 ng/ml), CNTF (10 ng/ml) and forskolin
(5 mM) as described (Meyer-Franke et al., 1995).
2.3. Immunohistochemical Staining of mAKAP in Adult Mice Retina
2-month old mice were euthanized by 100% CO2 inhalation. Eyes
were dissected and embedded in OCT for cryosection (10 μm) immedi-
ately. Sections were post-ﬁxed in 4% PFA for 15min and then washed 3
times in PBS. Retinal sectionswere blocked in 5%normal goat serumand
0.2% BSA in PBS for 30 min, then incubated for 1 h in the same buffer
with FL100 rabbit antibody to mAKAP 245–340 (Li et al., 2013). After
washing, retinal sections were incubated with Alexa 594-conjugated
goat anti–rabbit secondary antibody (1:500; Invitrogen) for 1 h, before
washing and mounting.
2.4. Western Blot Analysis
Protein extracts from acutely puriﬁed postnatal rat RGCs, adult
mouse brain and heart lysed in 20 mM HEPES, pH 7.4, 150 mM NaCl,
5 mM EDTA, 0.5% Triton, 50 mM NaF, 1 mM sodium orthovanadate,
1mMDTT, and protease inhibitorswere quantiﬁed using theDC Protein
Assay Kit II (Bio-Rad, California cat. 500–0112). Lysates were fractionat-
ed by SDS-PAGE and transferred to nitrocellulose membranes as previ-
ously described (Kapiloff et al., 1999, Yu et al., 2014). Western blots
were developed using horseradish peroxidase-conjugated, donkey sec-
ondary antibodies, Supersignal West Chemiluminescent Substrates
(Thermo Scientiﬁc) and a Fujiﬁlm LAS-3000 imaging system.
2.5. RT-PCR
Total RNA was extracted from RGCs transfected with mAKAP siRNA
or whole mouse retinas using a Qiagen RNeasy extraction kit (cat.
74104) and cDNA synthesis carried out using iScript reverse transcrip-
tase (Bio-Rad). Quantitative PCR (qPCR)was performed on the CFX Con-
nect Real-Time PCR System (Bio-Rad) using TaqMan Gene Expression
MasterMix (Life Tech; Cat#4369016)with the following conditions: ini-
tial denaturation 95°C for 6 min followed by 35 cycles of denaturation
(95°C for 45 s), annealing (58°C for 1 min) and extension (72°C for
1min). HPRT expression wasmeasured as a normalizer for each sample.
Results were analyzed by the relative quantity (ΔΔCt) method, as previ-
ously described (Thellin et al., 1999, Jiang et al., 2012). The primers were
as follows: HPRT (Life Tech; ID# Mm00446968_m1) and AKAP6
(ID#Mm01292745_m1).
2.6. RGC Survival and Neurite Growth Assays
Postnatal RGCswere electroporated immediately after isolationwith
control On-TARGETplus Non-targeting siRNA #1 (Thermoﬁsher) or
mAKAP ON-TARGETplus siRNA oligonucleotides (GAC GAA CCU UCC
UUC CGA A UU) as previously described (Corredor et al., 2012). RGCs
were then plated at low density (3000–5000 cells/well) on 48-well
plates in growth media containing forskolin, BDNF and CNTF. To inves-
tigate the role ofmAKAP in various neurotrophic signaling pathwayswe
also cultured siRNA transfected RGCs in growthmedia containing either
forskolin (5 μM) alone or forskolin with BDNF (50 ng/mL), CNTF
(10 ng/mL), EGF (10 ng/mL), or FGF (20 ng/mL). For survival assays,
RGCs were cultured for up to 3 days in growth media and then stained
with live cell marker calcein (C3100MP, Life Technologies), dead cell
marker sytox (S11368, Life Technologies), and Hoechst nuclear dye
(H1399, Life Technologies). RGC survival was expressed as the ratio of
total calcein-positive cells to calcein- and sytox-positive cells. For
neurite outgrowth assays, RGCs were cultured in growth media for
3 days. After ﬁxation in 4% PFA for 30 min and washing with PBS 3
times, RGCs were stained for βIII-tubulin and analyzed using ImageJ
Neurite Tracer or by Cellomics automated microscopy to quantify
neurite length. Over 300 cells per condition for each of three biological
Fig. 1.mAKAPα is expressed by RGCs. (A) Western blot demonstrated mAKAPα expression in postnatal day 3 rats RGCs and mice brain tissue. mAKAPβwas detected in control mouse
(WT) heart tissue, but not in cardiac-speciﬁc knock-out (KO) mice. *Non-speciﬁc band inconsistently detected in brain. (B–E) Cryosections from both adult wild-type (WT) and
Tg(Chx10-Cre);mAKAPﬂ/ﬂ (mAKAP KO) mouse retinas were immunostained for mAKAP (red) and nuclei counterstained with DAPI (blue). Speciﬁc mAKAP-staining was detected in the
ganglion cell layer of the WT retina (B and D, arrows) and potentially inner nuclear layer, but not in the Tg(Chx10-Cre);mAKAPﬂ/ﬂ retinal sections (C and E). Higher magniﬁcation of
the boxed region in D revealed that mAKAP expression is mainly perinuclear (D’). Scale bar in (B)–(E) represents 50 μm; Scale bar in (D’) represents 10 μm (N= 3).
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unexplained low survival in all conditions was excluded from analysis.
2.7. Intravitreal Injection and Optic Nerve Crush
AAV2-Cre (2 μL) was injected intravitreally into adult wildtype and
mAKAPﬂ/ﬂmice 2weeks prior to optic nerve crush. Intravitreal injections
were performed just posterior to the pars plana with a 31-gauge needle
(Hamilton) connected to a 5 μL Hamilton syringe. Care was taken not to
damage the lens. For nerve crush, the left optic nerve (ON)was exposed
from outer canthus, and crushed for 5 s with a Dumont # 5 forceps
(91150–20, F.S.T.) approximately 1.5 mm behind the globe. Care was
taken to avoid damaging the blood supply to the retina. Immediately
after optic nerve crush, separate cohorts of mice were treated with or
without BDNF (5 μg) or cAMP analog CPT-cAMP (Sigma; 50 μM) in
3 μL PBS. Mice with any signiﬁcant postoperative complications
(e.g., retinal ischemia, cataract) were excluded from further analysis.
2.8. Retrograde Labeling of RGCs and Quantiﬁcation of RGC Survival
Retrograde labeling with ﬂuorogold (FG; ﬂuorochrome) was per-
formed 1 week before optic nerve crush for assay of RGC survival, as
previously described (Chiu et al., 2008). In brief, the animals were anes-
thetized, and the skull exposed by amidline incision. Bilateral, 2-mmdi-
ameter craniotomies were placed 0.5 mm posterolateral to the sagittal
and transverse sutures. A small piece of gelfoam (Gelfoam, USP) soaked
in 4 μL 6% FG was then placed on the surface of the superior colliculus.
The incision was then sutured closed.
One week after optic nerve crush, mice were euthanized by perfu-
sion with 4% PFA. Retina ﬂat mount was prepared as described before
(Zhao et al., 2014). Brieﬂy, the eyes were removed and postﬁxed with
4% PFA for 2 h at room temperature. Retinas were ﬂat mounted in
mounting medium (H-1000; Vector) on glass slides. Confocal images
were acquired with a confocal laser scanning microscope (Leica DM
6000B; Leica Biosystems) and a ×40 magniﬁcation oil-immersion lens.
The imaging and quantiﬁcation were performed in a masked fashion.
The methods used for these procedures were adapted from previous
studies (Wang et al., 2013). Brieﬂy, the retinas were divided into 4quadrants and each quadrant was subdivided into 3 areas (central,
middle, and peripheral), which were 1, 2, and 3 mm from the optic
nerve head, respectively. One digital micrograph was randomly taken
from each of the 12 ﬁelds. Thus, 12 images were quantiﬁed per retina.
Fluorogold (FG)-positive cells were counted manually by one experi-
enced investigator masked to experimental group and presented as
cells/mm2 in each region. Microglia and macrophages, which may in-
corporate FG after phagocytosis of dying RGCs, were excluded based
on morphological criteria as described before: RGCs appear as large,
round cell bodies, no processes, almost homogenously labeled;
microglia appear as small elongated cell bodies, branching processes,
inhomogeneously labeled) (Biermann et al., 2011, Mansour-Robaey
et al., 1994, Kikuchi et al., 2000). Whole retinal RGC density was
estimated using the formula: (DC + 3DM + 5DP) / 9, where DC, DM,
and DP represent densities of the central, middle, and peripheral
regions, respectively. Each group contained at least 4 rats for obtaining
mean densities.
2.9. Statistical Analysis
All cohort sample sizes were determined based on previous power
calculations using variances determined in the prior publications
noted above. All datawere analyzedwith Student's t-test or 1-way anal-
ysis of variance using SPSS version 20.0 (SPSS Inc) and graphed using
Microsoft Ofﬁce Excel 2010. All data are displayed as means of at least
3 independent experimentswith standard error of themean (SEM). Sig-
niﬁcance is represented with asterisks.
3. Results
3.1. mAKAPα is Expressed by RGCs
We have previously shown that mAKAP is expressed in the brain
and striatedmuscle (Kapiloff et al., 1999).We now reveal that mAKAPα
is present in the retina. mAKAPα was detected by immunoblot in ex-
tracts prepared from puriﬁed postnatal day 3 (P3) rat RGCs (Fig. 1A).
A single band N250 kDawas detected in RGC extracts similar tomobility
tomAKAPα in brain. CardiacmAKAPβ, which is identical tomAKAPα aa
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smaller than the neuronal isoform (Michel et al., 2005) and migrated
faster in SDS-PAGE (Fig. 1A). By immunohistochemistry, staining for
mAKAPα was signiﬁcant in the retinal ganglion cell layer (Fig. 1B and
D, arrows) compared to control retinas from mAKAPﬂ/ﬂ;Tg(Chx10-cre)
mice lacking mAKAPα (Fig. 1C and E). Higher magniﬁcation images
demonstrate a perinuclear patterning for RGC mAKAPα (Fig. 1D’), con-
sistentwith its localization at thenuclear envelope inmyocytes and hip-
pocampal neurons (Michel et al., 2005, Pare et al., 2005).
3.2. Altering mAKAP Expression Levels Decreases RGC Survival and
Suppresses Neurite Extension In Vitro
Given the association of ERK5 and cAMP-signaling with mAKAP
signalosomes (Michel et al., 2005, Dodge-Kafka et al., 2005),we hypoth-
esized that the mAKAPα scaffold would be important for RGC survival
and neurite extension after stroke and nerve injury. To begin testing
this hypothesis, we cultured puriﬁed RGCs and either depleted
mAKAPα by RNA interference (RNAi) or overexpressed the scaffold by
transfection of a mAKAPα expression vector. Since we and others
have previously shown that both cAMP elevation and neurotrophic fac-
tors strongly promote RGC survival and axonal extension in primary
culture (Goldberg et al., 2002), RGCs were initially cultured in growth
media containing BDNF, CNTF, and forskolin (to activate adenylyl cy-
clases and elevate intracellular cAMP levels) in this study. In vitro cul-
ture and transfection of RGCs induces stress, resulting in ongoing cell
death even in neurotrophic factor-rich growth media, and serves as a
useful approach to mimic in vivo injury. Two days after electroporation
with mAKAP-speciﬁc siRNA, mAKAP mRNA expression was suppressed
~80% relative to control siRNA-treated cells (Fig. 2A). Notably, loss of
mAKAP expression caused a signiﬁcant decrease in RGC viability in cul-
ture (Fig. 2B and C), implying a role for mAKAPα signalosomes in neu-
ronal survival. Controls at 2 h after transduction showed no signiﬁcant
difference between the groups (~60% survival for both control and
mAKAP siRNA, data not shown), indicating that the effects of mAKAP
RNAi were not merely a result of differential electroporation.
Through the regulation of both common and distinct downstream
signaling pathways,most neurotrophic factors that support RGC surviv-
al also promote RGC axon growth (Goldberg et al., 2002). We next test-
edwhethermAKAPα expressionwas important for neurite extension in
cultured RGCs. RGCs were transfected with either mAKAP-targeting or
control siRNA and cultured in the presence of BDNF, CNTF and forskolin
to promote neurite elongation. Three days after transfection, cells were
ﬁxed and stained to allow for quantitation of the total neurite length of
the surviving RGCs. Following mAKAPα depletion, we found that mean
total neurite length was signiﬁcantly less compared to controls (Fig. 2D
and E). These results indicate that mAKAP in RGCs plays an integral role
in neurite outgrowth in response to neurotrophic factors and cAMP
elevation.
SincemAKAP depletion decreased RGCs sensitivity to neurotrophins
and cAMP, we hypothesized that overexpression of mAKAP scaffolds
may enhance neurotrophic responsiveness and by extension improve
survival and neurite outgrowth after an insult (i.e. transfection). Inter-
estingly, overexpression of either mAKAPα or the muscle mAKAPβ iso-
form also led to signiﬁcant cell death (Fig. 2F), and in the context of low
survival little neurite growth was observed (data not shown). This re-
sult is consistent with the readily saturated mechanism for mAKAP
peri-nuclear targeting by nesprin-1α (Pare et al., 2005) and the expect-
ed dominant negative effects of PKA displacement by introduction of
anchoring disruptor peptides (Scott et al., 2013). Together, these data
suggest that expression of mAKAPα at endogenous levels is required
for RGC survival.
Given mAKAPα's function as a signalosome scaffold and its role in
RGC survival and neurite growth, we tested whether the scaffold was
required for the function of speciﬁc neurotrophins in vitro. We cultured
puriﬁed RGCs electroporated with mAKAP or control siRNA in growthmedia containing either forskolin alone or in combination with 4 differ-
ent families of neurotrophic factors (BDNF, CNTF, EGF, or FGF) and
assayed cell survival and neurite growth.We found thatmAKAPα knock-
down signiﬁcantly reduced survival in RGCs cultured in forskolin with
BDNF or CNTF, but not in those cultured in forskolin alone or with EGF
or FGF (Fig. 2G). Furthermore, silencing mAKAP expression in RGCs
inhibited neurite outgrowth only in cells cultured in forskolin and
CNTF (Fig. 2H). These results demonstrate that mAKAP is required in
RGCs for the transduction of pro-survival signaling induced by BDNF
and CNTF, and pro-growth signaling induced by CNTF, and support a
broader, but potentially selective role for mAKAP signalosomes in
neuroprotection.
3.3. mAKAPα is Dispensable for RGC Survival During Development and in
the Adult
Because RGC survival and axon growth in vitro depended upon
mAKAPα, we tested whether mAKAPα expression was important for
RGC development in vivo. mAKAPα expression in retinal development
was ablated by mating Tg(Math5-cre) driver mice, that express cre
recombinase in the progenitors responsible for most postnatal RGCs
(Brzezinski et al., 2012), to aﬂoxed, conditionalmAKAP allelewe recent-
ly described (Kritzer et al., 2014b). Flat mounts of retinas frommAKAPﬂ/
ﬂ;Tg(Math5-cre) mice and littermate mAKAPﬂ/ﬂ controls lacking cre
(WT)were stainedwith Brn3 and TUJ1 to label RGC soma and axons, re-
spectively (Fig. 3A and B). No difference in RGC numbers or their axon
bundles in the optic nerve ﬁber layer were observed between mAKAPﬂ/
ﬂ;Tg(Math5-cre) and WT mice (Fig. 3C). These data suggest that
mAKAPα is not necessary for the generation of normal numbers of
RGCs during development or for proper intraretinal axon growth or
guidance.
Since we did not observe a deﬁcit in retinal developmental in
mAKAPα KO animals, we next asked whether mAKAPα knock-out in
the mature retina would impair RGC survival. To induce RGC-selective
conditional knock-out, AAV2-cre was injected intravitreally in adult
mAKAPﬂ/ﬂ mice. Retrograde labeling of RGCs with ﬂuorogold (FG) was
performed 1 week after virus injection. Two weeks after injection, the
morphology of the FG labeled RGCs in mAKAP knockout mice was sim-
ilar to those in control animals; neither phagocyte activation nor RGC
scavenging was observed (Fig. 3D and E). No difference in number of
FG-labeled RGCs was observed between mAKAPα-knockout and con-
trol AAV2-cre injected WTmice (Fig. 3F). Thus, persistent mAKAPα ex-
pression is not required for RGC survival in the unstressed adult retina.
3.4. mAKAPα Contributes to RGC Survival After Optic Nerve Injury
There are signiﬁcant differences between the mechanisms confer-
ring RGC survival during development and those conferring survival fol-
lowing injury in the adult (Huang et al., 2014). We considered that in
contrast to the apparent unimportance of mAKAPα to RGC develop-
ment, the results regarding mAKAPα obtained in vitro in “stressed”
RGCs may have reﬂected a requirement for mAKAPα in vivo during
stress conditions such as those that occur in optic nerve injury or stroke.
To address this hypothesis, we assayed mAKAPα protein and mRNA
levels after optic nerve crush, a model for adult nerve injury, and an ex-
periment more readily interpretable than comparing protein levels
in vivo to those in vitro after injury. We assayedmAKAPα protein levels
in RGCs three days after optic nerve crush and found a signiﬁcant reduc-
tion (~40–50%) compared to uninjured controls (Fig. 4A and B). Retinal
mAKAP transcripts were similarly reduced (Fig. 4C). Note that the de-
crease in mAKAPα levels was not due to lower RGC numbers, as in
this model, RGCs begin to die 3–5 days after injury, with apoptosis
peaking 1–2 weeks later (data not shown and (Berkelaar et al.,
1994)). Thus, loss of mAKAPα was associated with the induction of
RGC death following trauma.
Fig. 2.Requirement formAKAP expression in RGC survival in vitro. (A) Quantitative PCR revealed thatmAKAPmRNA expressionwas inhibited 80% 2 days after electroporation bymAKAP
siRNA compared to control siRNA. (B) Puriﬁed primary RGCs electroporated with either control or mAKAP siRNA were cultured in growth media containing BDNF, CNTF and forskolin.
Representative images of cells stainedwith calcein (live cell marker, green) and sytox (dead cell marker, red) at different time points after electroporation are shown. Scale bar represents
100 μm. (C) RGC survival normalized to the control siRNA-treated RGCs for the respective time point (N=4). Two hours after electroporation, no difference in RGC survival was observed
between control andmAKAP siRNA-treated RGCs. However, survival of mAKAP siRNA-treated RGCs after 2 and 3 days in vitro (DIV)was signiﬁcantly lower than for control siRNA-treated
RGCs. (D) PuriﬁedprimaryRGCs electroporatedwith either control ormAKAP siRNAwere cultured in growthmedia containingBDNF, CNTF and forskolin for 3 days. Representative images
of βIII tubulin immunostaining (neurite marker) are shown. Scale bar represents 50 μm. (E) Mean total neurite length per cell normalized to that for control siRNA (N= 4). Neurite ex-
tension was signiﬁcantly longer in control cells than mAKAP siRNA treated cells. (F) Overexpression of mAKAPα and –β signiﬁcantly reduced RGC survival compared to GFP transfected
controls (N= 3). (G) Survival of RGCs electroporatedwithmAKAP or control siRNA and cultured inmedia with orwithout growth factors, normalized to control siRNA-treated RGCs cul-
tured inmediawithout growth factor (MM). Survival was reduced bymAKAP RNAi for cells cultured in forskolinwith BDNF or CNTF, but not those cultured in forskolin alone or with EGF
or FGF. Representativedata from repeated experiments shown(N=3). (H)Mean total neurite lengthofmAKAP and control siRNA-treatedRGCs cultured inmediawith orwithout growth
factors, normalized to control siRNA-treated RGCs cultured in media without growth factor (MM). Neurite growth was signiﬁcantly inhibited by mAKAP RNAi only for RGCs cultured in
forskolin and CNTF (N= 3). *P b 0.05, **P b 0.01; Student's t-test; error bars indicate standard error of mean.
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RGC death following trauma by removing any residual RGC mAKAPα
expression via mAKAP gene deletion. We found that after optic nerve
crush, the survival of RGCs in AAV2-cre injectedmAKAPﬂ/ﬂmicewas sig-
niﬁcantly less than that in AAV2-cre injectedwild-type controls (Fig. 4F,
G and N).We and others have previously reported that BDNF and cAMP
improve RGC survival following nerve injury (Mo et al., 2002, Goldberg
et al., 2002, Corredor et al., 2012). As before, intravitreal injection of
BDNF and/or the cAMP analog CPT-cAMP signiﬁcantly increased RGC
survival in AAV2-cre injected wild-type animals after optic nerve
crush (Fig. 4H, J, L and O). Remarkably, however, neither BDNF, nor
CPT-cAMP, nor their combination was able to promote RGC survival
after crush injury in AAV2-cre injected mAKAPﬂ/ﬂ mice (Fig. 4I, K, M
and P). Together, these results show that mAKAPα is required for bothendogenous signaling and signaling induced by exogenous BDNF and
cAMP that promote RGC survival after optic nerve injury.
4. Discussion
Here we document a stress-speciﬁc neurotrophic factor signaling
pathway in CNS neurons, identifying the physiologic function for
mAKAPα in regulation of RGC survival and neurite growth. We show
that mAKAPα is expressed in RGCs in the mature retina, and using
RNA interference and conditional gene deletion, that mAKAPα supports
the survival and neurite extension of primary neurons in vitro and the
survival of RGCs in vivo after optic nerve injury.
The central observation of our study is that mAKAPα is required for
pro-survival signaling in RGCs after optic nerve injury in the adult, but
Fig. 3. Retina-speciﬁc mAKAP knockout during development orwhen induced in the adult has no effect on RGC number. (A and B) Retinal ﬂatmount from adult Tg(Math5-cre);mAKAPﬂ/ﬂ
knock-outmice and littermatemAKAPﬂ/ﬂ controls lacking cre (WT)were stainedwith Brn3 (retinal ganglion cellmarker, red), and βIII-tubulin (neuritemarker, green) and counterstained
with DAPI (nuclear marker, blue). Representative images of retinal segments are shown. Scale bar represents 50 μm. (C) RGC quantiﬁcation demonstrated no difference in the number of
Brn3-labeled RGCs between knock-out and control animals (n= 4mice per group). (D and E) AAV2-Cre intravitreal injection of control WT andmAKAPﬂ/ﬂmice to knock out mAKAPα in
the adult retina. RGCs were retrogradely labeled with ﬂuorogold (FG). Representative images of retinal segments are shown. Scale bar represents 50 μm. (F) RGC quantiﬁcation demon-
strated a similar number of RGCs in bothWT andmAKAPﬂ/ﬂ animals twoweeks after AAV2-cre application (n=4mice per group). n.s.: not signiﬁcant; Student's t-test; error bars indicate
standard error of mean.
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implies that divergent signaling pathways control neuronal survival
during development and following injury. These results are reminiscent
of those recently found following mAKAPβ knock-out in the cardiac
myocyte wherein mAKAPβ was dispensable in the developing heart,
but required for the induction of pathological cardiac remodeling fol-
lowing pressure overload or catecholamine infusion (Kritzer et al.,
2014a). Taken together, these data suggest that mAKAP signalosomes
play critical roles in the regulation of intracellular signaling pathways
invoked in disease or injury.
Interruption of target-derived neurotrophic support is a key factor
diminishing RGC survival following axon injury (Yip and So, 2000,
Shen et al., 1999, Moore and Goldberg, 2010). Following optic nerve
crush, trophic survival signaling can be induced by exogenous BNDF
or cAMP (Shen et al., 1999), but here we ﬁnd that this signaling was ef-
fective in promoting survival only in RGCs expressing mAKAPα. We
found endogenous mAKAPα expression dropped signiﬁcantly in RGCs
after optic nerve crush, contemporaneously with the induction of RGC
death. Complete loss of mAKAPα via gene deletion further exacerbated
RGC loss. In addition, any enhancement of RGC survival by exogenous
cAMP and/or BDNF after injury depended upon the residual (50–60%)
mAKAPα normally expressed after optic nerve crush-mediated protein
down-regulation. mAKAPα overexpression was also deleterious to cul-
tured RGCs, conﬁrming that overexpression of binding proteins for crit-
ical signaling proteins are often disruptive to signaling pathways (Scott
et al., 2013). Together our data imply that the organization of
perinuclear signalosomes by the mAKAPα scaffold is limiting for the
transduction of cAMP and neurotrophic factor signaling required for
RGC survival following trauma or insult.
Neurotrophic factors regulate RGC survival and neurite growth
through both common and distinct downstream signaling pathways
(Goldberg et al., 2002). For example, MAPK/ERK and PI3K/AKT signaling
pathways are involved in BDNF induced neuronal survival and axonalgrowth (Nakazawa et al., 2002)whereas CNTF elicits its biological actions
through JAK/STAT3, PI3K/AKT, and MAPK/ERK signaling pathways
(Goldberg et al., 2002, Ip and Yancopoulos, 1996, Peterson et al., 2000,
Dolcet et al., 2001, Kaur et al., 2002). Themechanisms howmAKAPα scaf-
folding contributes to neurotrophic dependent- and/or independent-RGC
survival and axon growth will need to be elucidated in future studies. As
indicated above, mAKAPα can target both ERK5 and PKA to the neuronal
nuclear envelope (Michel et al., 2005). MAPK signaling is critical for the
survival effects of neurotrophic factors in RGCs (Goldberg et al., 2002).
In RGCs and other neurons, ERK5mediates neurotrophin-dependent (in-
cluding BDNF), retrograde pro-survival signaling that is initiated in the
axon (Watson et al., 2001, Pazyra-Murphy et al., 2009, Wang et al.,
2006, van Oterendorp et al., 2014). cAMP also potentiates CNS neuronal
survival and axon growth in response to neurotrophic factors (Goldberg
et al., 2002). The underlyingmechanism for this potentiation remains ob-
scure, but likely involves crosstalk between activity-induced, Ca2+-
dependent signaling pathways and neurotrophic factor-induced MAPK
signaling pathways (Steinberg and Brunton, 2001). mAKAPα provides a
potential platform for such crosstalk, since it binds machinery critical to
both cAMP and MAPK signaling (Dodge-Kafka et al., 2005). Both ERK5
and its upstream activator, MEK5, indirectly bind mAKAP through the
phosphodiesterase PDE4D3 (Dodge-Kafka et al., 2005). Interestingly,
ERK5 phosphorylation of PDE4D3 has been shown to inhibit local cAMP
degradation, increasing PKA activity (Dodge-Kafka and Kapiloff, 2006).
Thus, at mAKAPα signalosomes cAMP and MAPK signaling can synergis-
tically oppose retrograde cell death after axon injury (Fig. 4Q). Howdiffer-
ent signaling pathways are involved, and balanced in the mAKAPα
complex for particular function (neuronal survival and/or neurite
growth) under different conditions are of great interest and will need to
be further elucidated in future studies.
Other mAKAP binding partners have been reported to promote the
survival and axon growth of CNS neurons, including for example, the
Ca2+/calmodulin-dependent phosphatase calcineurin and the
Fig. 4. Loss of mAKAP exacerbates RGC cell death after optic nerve injury. (A) Western blot for mAKAP and ERK1/2 protein in uninjured RGCs and 3 days after optic nerve crush (ONC).
(B) Quantitation of protein expression revealed a 40–50% reduction in RGCmAKAPα levels compared to uncrushed controls (N= 3). (C) Quantitative PCR demonstrating a similar reduc-
tion in retinal mAKAPαmRNA expression 3 days after crush injury (n= 3). (D–P) InducedmAKAP knockout (KO) in the adult suppresses RGC survival after optic nerve injury. AAV2-cre
was injected intravitreally inmice 2 weeks prior to optic nerve crush. RGCs were retrogradely labeledwith ﬂuorogold 1 week prior to optic nerve injury. (D–M) Representative images of
ﬂat-mounted retinal segments in different conditions as marked. Scale bar represents 100 μm. (N–P) Quantiﬁcation of RGC survival. A similar number of RGCs was observed in WT and
mAKAP KOmice (mAKAPﬂ/ﬂ animals with AAV2-cre injection) following sham optic nerve injury (exposed optic nerve, without crush). By one week after optic nerve crush, however, sig-
niﬁcantly fewer ﬂuorogold-labeled RGCs were observed in mAKAP knockout animals than control animals (N). Application of BDNF and cAMP signiﬁcantly increased RGC survival after
optic nerve injury inWT animals (O), but had noeffect onmAKAPKOmice (P) (n=4mice per group). *Pb 0.05, **P b 0.01; one-way analysis of variance; error bars indicate standard error
ofmean. (Q)Model formAKAPα-dependent signaling in stressed RGCs. mAKAPα can organize signalosomes that contain signalingmolecules such as ERK5 and PKA that are responsive to
upstream neurotrophin and electrical signals and that we propose will induce gene expression promoting both RGC survival and neurite outgrowth following injury.
1886 Y. Wang et al. / EBioMedicine 2 (2015) 1880–1887transcription factor MEF2 (Passariello et al., 2015, Akhtar et al., 2012).
The unique mAKAPα N-terminal domain not present in mAKAPβ can
directly bind PDK1 (Michel et al., 2005). PDK1 binding to mAKAPα
can contribute to the activation of p90 ribosomal S6 kinase (RSK) that
promotes neuronal survival in response to neurotrophic factors by
both transcription-dependent and -independent mechanisms. For ex-
ample, by direct phosphorylation RSK inactivates BAD, a pro-apoptotic
protein family member, and activates transcription factor cAMP re-
sponse element-binding protein (CREB) (Bonni et al., 1999).
In conclusion, we have identiﬁed mAKAPα expression in RGCs and
demonstrated a requirement for mAKAPα in neuronal survival and
neurite growth in cell culture and after optic nerve injury in vivo. Future
studies will identify the mAKAPα-orchestrated signaling modules rele-
vant to these processes and may suggest targets for neuroprotection
after acute injury or in neurodegenerative disease.Author Contributions
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